Financials
Financial year 2024
YACA PHARMA LABORATOIRES from Frasnes-lez-Anvaing, company number BE0833843969, closed financial year 2024 with a result of € 31,771 after tax. For that financial year YACA PHARMA LABORATOIRES recorded a gross margin of € 123,041 and equity of € 399,574. Compared with financial year 2023, the result moved from € 21,739 to € 31,771. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on November 18, 2025.
€ 399,574
▲ 9% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 31,771
▲ 46% vs 2023
Profit after tax over the fiscal year.
€ 150,364
▲ 51% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 379,114.
People and assets in 2024
€ 16
▼ 94% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2024
€ 808,333
▲ € 783,333 vs 2023
€ 28,968 is repaid this year. At this pace the long-term loan is gone in ≈ 28 years.
€ 35,481
▲ 116% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 2,994
▼ 65% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 79,145 | € 42,092 | € 92,236 | € 123,041 | ▲ 33% |
| Profit after taxes | € 21,450 | € -19,476 | € 21,739 | € 31,771 | ▲ 46% |
| Equity | € 365,540 | € 346,064 | € 367,803 | € 399,574 | ▲ 9% |
| Total debts | € 95,651 | € 90,820 | € 104,948 | € 904,867 | ▲ € 799,919 |
| Cash | € 169,114 | € 24,723 | € 99,577 | € 150,364 | ▲ 51% |
| Land & buildings | - | € 119,701 | € 119,701 | € 849,846 | ▲ € 730,145 |
| Retained profit | € 346,940 | € 327,464 | € 349,203 | € 379,114 | ▲ 9% |
| Bank debt | € 25,000 | € 25,000 | € 25,000 | € 808,333 | ▲ € 783,333 |
| Balance sheet total | € 461,191 | € 436,884 | € 472,751 | € 1,304,441 | ▲ 176% |
Key figures of YACA PHARMA LABORATOIRES, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to YACA PHARMA LABORATOIRES?
What happened at YACA PHARMA LABORATOIRES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 31,771 (▲ 46% vs 2023). filed late Source: NBB ↗
- Angélique DUMONT became a director. NBB
- YACA PRENDRE-TAKE-NEMEN SARL became a director. NBB
- New establishment in Ittre. KBO
- Start of the company according to the CBE. KBO
In short
From € 21,450 profit in 2021 to € 31,771 profit in 2024.
Paid € 37,916 in corporate taxes since 2021.
Best year ever: 2024, with € 31,771 profit.
A new publication or filing at YACA PHARMA LABORATOIRES? We notify you, reason included.
Follow YACA PHARMA LABORATOIRESDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind YACA PHARMA LABORATOIRES are Angélique DUMONT and YACA PRENDRE-TAKE-NEMEN SARL.
Directors
According to the 2024 annual accounts
Angélique DUMONT
Director
since 2016
YACA PRENDRE-TAKE-NEMEN SARL
Director
since 2016
Establishments
Establishment units
Physical locations of this company
Rue Henri Lemaire(FB) 17
7911 Frasnes-lez-Anvaing
Chaussée de Nivelles 32
1461 Ittre
Active since 1 October 2014
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0833.843.969
- VAT number
- BE 0833.843.969
- Registered office
- Rue Henri Lemaire(FB) 17, 7911 Frasnes-lez-Anvaing
- Names & denominations
- YACA PHARMA LABORATOIRES
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 January 2011
- Peppol
- Active · Active since 27 Jan 2026
- Activities · NACE
Vervaardiging van andere voedingsmiddelen, neg
Vervaardiging van overige farmaceutische producten
Activiteiten van medische beeldvorming en medische laboratoria
Vervaardiging van geneesmiddelen
Vervaardiging van farmaceutische grondstoffen
Activiteiten van medische laboratoria